Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer.
Ghadjar P, Hayoz S, Genitsch V, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Khanfir K, Budach V, Aebersold DM, Thalmann GN; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: kranzbuhler h. BJU Int. 2017 Nov;120(5B):E45-E51. doi: 10.1111/bju.13742. Epub 2017 Jan 19. BJU Int. 2017. PMID: 27987524 Free article.
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.
Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Gomez S, Wust P, Thalmann GN, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Eur Urol. 2021 Sep;80(3):306-315. doi: 10.1016/j.eururo.2021.05.033. Epub 2021 Jun 14. Eur Urol. 2021. PMID: 34140144 Clinical Trial.
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P. Sassowsky M, et al. Among authors: kranzbuhler h. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):534-41. doi: 10.1016/j.ijrobp.2013.06.2053. Epub 2013 Aug 22. Int J Radiat Oncol Biol Phys. 2013. PMID: 23972722 Clinical Trial.
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.
Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Kaouthar K, Wust P, Thalmann GN, Aebersold DM. Ghadjar P, et al. Among authors: kranzbuhler h. J Clin Oncol. 2015 Dec 10;33(35):4158-66. doi: 10.1200/JCO.2015.63.3529. Epub 2015 Nov 2. J Clin Oncol. 2015. PMID: 26527774 Clinical Trial.
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).
Allal AS, Ares C, Dulguerov P, Tschanz E, Verdan C, Mhawech P, Riesterer O, Honer M, Vuong V, Jochum W, Zingg D, Bodis S, Ametamey S, Pruschy M, Inteeworn N, Ohlerth S, Höpfl G, Roos M, Wergin M, Rohrer Bley C, Gassmann M, Kaser-Hotz B, Berthou S, Aebersold DM, Ganapathipillai S, Streit B, Stalder D, Gruber G, Greiner RH, Zimmer Y, Lutters G, Krek W, Tenzer A, Hofstetter B, Bonny C, Azria A, Larbouret C, Cunat S, Ozsahin M, Zouhair A, Gourgou S, Martineau P, Evans DB, Romieu G, Pujol P, Pèlegrin A, Heuberger J, Kestenholz P, Taverna Ch, Lardinois D, Jörger M, Schneiter D, Jerman M, Weder W, Stahel R, Bodis S, Vees H, Mach N, Hügli A, Balmer Majno S, Beer KT, Friedrich EE, Ciernik IF, Stanek N, Taverna C, Greiner R, Mahler F, Landmann Ch, Studer G, Bernier J, Gallino A, Juelke PD, Hafner HP, Jamshidi P, Erne P, Resink TJ, Thum P, Notter M, Bargetzi M, Suleiman M, Luthi JC, Bieri S, Curschmann J, Pajic B, Kranzbühler H, Lippold B, Ueltschi G, Bonetti M, Nasi ML, Price KN, Castiglione-Gertsch M, Rudenstam CM, Holmberg SB, Lindtner J, Gol-Ouh R, Collins J, Crivellari D, Carbone A, Thürlimann B, Simoncini E, Fey MF, Gelber RD, Coates AS, Goldhirsch A, Jeanneret Sozzi W, Kramar A… See abstract for full author list ➔ Allal AS, et al. Among authors: kranzbuhler h. Strahlenther Onkol. 2004 Jun;180 Suppl 1:89-108. doi: 10.1007/BF03356735. Strahlenther Onkol. 2004. PMID: 27137923 No abstract available.
Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer.
Ferraro DA, Garcia Schüler HI, Muehlematter UJ, Eberli D, Müller J, Müller A, Gablinger R, Kranzbühler H, Omlin A, Kaufmann PA, Hermanns T, Burger IA. Ferraro DA, et al. Among authors: kranzbuhler h. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):652-664. doi: 10.1007/s00259-019-04568-1. Epub 2019 Dec 4. Eur J Nucl Med Mol Imaging. 2020. PMID: 31802175
Abstracts der 3. Gemeinsamen Brachytherapiekonferenz SASRO/DEGRO/OEGRO.
Ott OJ, Strnad V, Pötter R, Hammer J, Hildebrandt G, Resch A, Kovács G, Beckmann MW, Sauer R, Niehoff P, Polgar C, Ostertag H, Major T, Eidtmann H, Jonat W, Kimmig B, Roddiger SJ, Kolotas C, Kuner RP, Martin T, Kurek R, Baltas D, Rogge B, Kautschur H, Hoffmann G, Pollow B, Kontova M, Zamboglou N, Ott O, Lotter M, Gallino A, Mahler F, Niewald M, Jafari F, Hennen B, Wisser L, Fleckenstein J, Rübe Ch, Böhm M, Micke O, Wagner W, Schäfer U, Willich N, Greiner RH, Pallas A, Pajic B, Collen T, Meurer N, Töpfer M, Ries G, Leutloff U, Frei S, Warszawski A, Baumann R, Möller T, Niedermeyer J, Karstens JH, Gripp S, Muskalla K, Pulte T, Ohmann C, Röddiger S, Dannenberg T, Tunn UW, Dimopoulos J, Schard G, Kirisits C, Lang S, Goldner G, Wachter S, Wachter-Gerstner N, Helbich T, Weise C, Bendel M, Kocher M, Müller RP, Engelmann U, Aebersold DM, Isaak B, Vetterli D, Kemmerling L, Thalmann G, Behrensmeier F, Mini R, Baier K, Wulf J, Nürnberg N, Egberts J, Galalae R, Maurer U, Maurer G, Lang K, Zumbé J, Block T, Czempiel H, Machtens S, Ponholzer A, Riedl A, Oismüller R, Somay C, Hawliczek R, Maier U, Madersbacher S, Hoinkis C, Winkler C, Lehmann D, Hakenberg O, Herrmann T, Messer PM, Gottfried HW, … See abstract for full author list ➔ Ott OJ, et al. Among authors: kranzbuhler h. Strahlenther Onkol. 2004 Jun;180 Suppl 1:109-28. doi: 10.1007/BF03356736. Strahlenther Onkol. 2004. PMID: 27137924 German. No abstract available.
Improved treatment outcome and lower skin toxicity with intensity-modulated radiotherapy vs. 3D conventional radiotherapy in anal cancer.
Sauter M, Lombriser N, Bütikofer S, Keilholz G, Kranzbühler H, Heinrich H, Rogler G, Vavricka SR, Misselwitz B. Sauter M, et al. Among authors: kranzbuhler h. Strahlenther Onkol. 2020 Apr;196(4):356-367. doi: 10.1007/s00066-019-01534-6. Epub 2020 Jan 24. Strahlenther Onkol. 2020. PMID: 31980834 Free article. English.
13 results